Ã÷ÐÇ°ËØÔ

Summary

Subhash Pokhrel, PhD is a professor of health economics and the Lead, Health Economics Research Group (HERG). Most recently, he was the Head of Department of Health Sciences (2018-2023), an academic department comprising allied health professions, nursing, social work, health economics and public health. Prior to that, he was the Founding Divisional Lead of (now) the Division of Global Public Health (2016-18). From 2013-16, he developed and led a large-scale, multi-country (n=11), multi-disciplinary research project, EQUIPT, providing European policymakers with the decision-support evidence and tools around tobacco control.  In addition to the UK and EU, Subhash has research experience in several low- and middle-income countries (LMICs) including Nepal, India, Bangladesh, Pakistan, Burkina Faso, Ghana, Brazil and Indonesia. Subhash has worked together with the World Health Organisation to strengthen National Health Research Systems (NHRSs), particularly in LMICs.     

Subhash's research is focussed on two complementary themes: supporting 'health systems' to deliver efficient healthcare as well as strengthening 'health research systems' to support more research into healthcare. As such, his research has contributed to several public health policies. The two REF2021 impact case studies - and  describe Subhash's and generate significant impact from them. His about how researchers can engage with and support goverments and wider stakeholders to is underpinned by his and colleagues' earlier work around the suite of . These ROI tools provided the basis for many public health investment decisions in England and were informed by the work on tobacco control led by Subhash. The ROI tools are practical, customisable models to help make real-world decisions in context of local, regional and national government decision-making.

Economic arguments are needed to make the business case for public health investments. Subhash led the of ROI work to several European nations through a €2 million multi-centre European Commission funded study, . He has been the coordinator of a large scale inter-disciplinary collaboration of national and international expertise. Subhash is the lead author of a book, (Palgrave Macmillan).

Subhash’s work in public health research has been as diverse as the discipline itself – from developing a household decision making pathway for care in low- and middle income countries (LMICs) to quantifying the economic impact of  promotion in industrialised countries; from evaluating for its population health impact in LMICs to finding out what interventions could improve  globally.

His doctoral researchers have investigated whether , particularly , are effective; what determines obesity in West Africa and particularly ; and what the were. His visiting student from Sri Lanka has investigated the . Such research evidence, particularly in LMICs, is key to developing and evaluating public health measures for their value for money.  

Subhash is intrigued not only by "health systems" questions (e.g. In LMICs and industrialised countries, what works to improve population health outcomes and at what cost?) but also by "health research systems" questions. Subhash worked with the WHO Euro to on policies, interventions and tools for establishing and/or strengthening national health research systems and their effectiveness. In particular, Subhash and colleagues have investigated (particularly economic evaluations) into policymaking in Spain and what implications the Spanish experience could have globally for strenthening both systems.

As a member of various external committees (NICE Technology Appraisal, NIHR PGfAHR and SPI-B), Subhash has contributed to decision making processes around funding of medical technologies, research in applied health, and behavioural measures to tackle public health emergencies.       

Responsibility

Leader, Health Economics Research Group (HERG)

Former Head of Department of Health Sciences (2018-2023)

Founding Divisional Lead of Global Public Health Divison (2016-2018)

Ex-Module Lead: Economic Evaluation in Human Genomics in MSc Genomic Medicine (Imperial College London)

Lead, European-study on quanitfying utility of investment in protection from tobacco ()